|
 |
Biomarkers in Clinical Trials |
 |
|
23-24 September 2009
London, UK
With an exceptional line-up of speakers, SMi’s Biomarkers in Clinical Trials conference will demonstrate the way forward in designing phase I, II and III trials and present you with a fresh perspective on biomarker application in drug development.
This unique event is designed to help you realise the potential of your products in the most efficient way possible and is an essential addition to the calendar of all those working in the industry.
Attend and gain insights into the use of biomarkers as a way of accelerating the approval or withdrawal of a product. You will have the chance to network with industry associates and the opportunity to explore ways in which you can integrate biomarkers into your own drug development processes.
To find out more about the conference visit: www.smi-online.co.uk/biomarkers-ct1.asp
This conference will also be focusing on the following areas:
- Transfer of biomarkers to clinical practice
- Biomarkers in early clinical drug development
- Biomarkers in later stage clinical trials (phase II and III)
- Examples of successful use of biomarkers in clinical trials
- Potential for saving money by using biomarkers
- Biomarkers for disease modification in chronic disease
- Pre-clinical/clinical modeling
- Utilising positive and negative effect biomarkers in clinical trials
To take advantage of our early-bird discount, call Zain Philbey on +44 (0) 20 7827 6722 or email zphilbey@smi-online.co.uk |
|
|
|
|
|
 |
|
|
 |
Industry Events |
 |
P-MEC Europe
5-7 October 2010, Paris, France
Hosted alongside CPhI, ICSE and BioPh, P-MEC (The Pharmaceutical Machinery and Equipment Convention) was first held in Madrid in 2005 and has since rapidly grown into a must-attend event for both sellers and buyers of pharmaceutical processing and manufacturing equipment. Now covering every aspect of pharma and biotech equipment, laboratory and analytical techniques to track & trace technologies, P-MEC Europe 2010 offers a perfect synergy between its sister events ICSE (The International Contract Services Expo) and BioPh Europe (bio solutions for pharma).
More info >> |
|
 |
News and Press Releases |
 |
ClinTec International
ClinTec International, a global Clinical Research Organisation (“CRO”) announces a financial and strategic partnership with Elephant Capital Plc., an AIM market listed private equity firm. With an investment of £8 Million GBP, Elephant has acquired a significant minority stake in ClinTec. Through this investment, Elephant has entered the attractive clinical research base, where ClinTec operates as a global provider of outsourcing solutions addressing the drug development lifecycle. Managing Partner of Elephant Capital LLP, Gaurav Burman, and Non-Executive Director of Elephant Capital Plc, James Hauslein, have also made personal co-investments in this transaction.
More info >> |
|
|
